JBM  Vol.6 No.5 , May 2018
Study of Xanthine Oxidase Activity in Sera of Iraqi Children with Nephrotic Syndrome
Abstract: Introduction: To investigate the relationship of xanthine oxidase activity with nephrotic syndrome disorder in children, and the optimization of the enzyme activity conditions in the disorder. Material and methods: Sera of children with nephrotic syndrome (NS) (60 samples) were obtained from Central Child Teaching Al Karama Hospital (CCTAH), from 2nd Mar. 2013 to 28th Feb. 2014. Sera of the patients were assayed for xanthine oxidase (XO) activity using colorimetric absorbance technique. The obtained results were compared with the enzyme activity of normal children (70 samples) as control. Results and conclusions: The results revealed a significant (P < 0.001) elevation in XO activity in serum of nephrotic syndrome (0.12 ± 0.06 IU/L) compared with that of normal subjects (0.05 ± 0.009 IU/L), showing an elevation of (70%) in XO activity (about 2/3) that of normal group. Factors influencing XO activities were also studied and showed that XO activity is a pH dependent. Significant elevation (P < 0.001) was found in uric acid level in sera of NS patients (497.52 ± 3.21 μmol/L) compared with that in normal group (298.12 ± 1.70 μmol/L). Elevation was found in urea level in sera of NS patient (10.69 ± 7.55 mmol/L) compared with that of normal group (4.57 ± 1.27 mmol/L). It was appeared, there is a role of XO activity in the pathogenesis of endothelial injury during glomerular lesion in NS and that was confirmed by comparing XO activity and other related conditions with the activity of normal volunteers.
Cite this paper: Asad Qadir, V. , Nouri Ahmed, S. and Rostum Ali, D. (2018) Study of Xanthine Oxidase Activity in Sera of Iraqi Children with Nephrotic Syndrome. Journal of Biosciences and Medicines, 6, 126-135. doi: 10.4236/jbm.2018.65014.

[1]   Davin, J.C., Tenberg, I.J. and Weening, J.J. (2001) What Is the Difference between IgA Nephropathy and Henoch-Schonlein Purpura Nephritis? Kidney International Journal, 59, 823-834.

[2]   Niaudet, P. (2004) Steroid-Sensitive Nephrotic Syndrome in Children. In: Avner, E.D., Harmon, W.E. and Neasden, P., Eds., Paediatric Nephrology, Lippincott Williams and Wilkins, Philadelphia, 543-556.

[3]   Kher, K., Schnaper, H.W. and Greenbaum, L.A. (1990) Clinical Pediatric Nephrology. 3rd Edition, CRC Press and Francis Group, Boca Raton, London, New York, 307.

[4]   Kelly, C.R. and Landman, J. (2012) The Netter Collection of Medical Illustrations-Urinary System. Elsevier Health Sciences, Permissions for Netter Art Figures may be sought directly from Elsevier’s Health Science Licensing, 101.

[5]   Mendoza, S.A. and Tune, B.M. (1999) Treatment of Childhood Nephritic Syndrome. Journal of the American Society of Nephrology, 3, 889-894.

[6]   Korbet, S.M., Schwartz, M.M. and Lewis, J.E. (1994) Primary Focal Segmental Glomerulosclerosis: Clinical Course and Response to Therapy. American Journal of Kidney Disease, 6, 773-783.

[7]   Glassock, R.J. (1989) Proteinmia. In: Textbook of Nephrology, 2nd Edition, Williams & Willkins, Baltimore, 189-197.

[8]   Brenner, B.M. and Eger, N. (1978) No Evidence of Sevoflurance Induced Renal Injury in Volunteers. Journal of Medicine, 87, 230-231.

[9]   Enorth, C., Eger, B.T., Okamoto, K., Nishino, T. and Pai, E.F. (2000) Crystal Structures of Bovine Milk Xanthine Dehydrogenase and Xanthine Oxidase: Structure-Based Mechanism of Conversion. PNAS, 97, 10723-10728.

[10]   Metz, S. and Thiel, W. (2009) A Combined QM/MM Study on the Reductive Half-Reaction of Xanthine Oxidase: Substrate Orientation and Mechanism. Journal of the American Chemical Society, 131, 14885-14902.

[11]   Serafi, S.V., Taremi, C. and Osborn, M. (2011) Waves in a Hypothermic Patient. The Journal of Community Hospital Internal Medicine Perspectives, 1, No. 4.

[12]   Battelli, M.G., Musiani, S., Valgimigli, M., Gramantieri, L., Tomassoni, F., Bolondi, L. and Stirpe, F. (2001) Serum Xanthine Oxidase in Human Liver Disease. The American Journal of Gastroenterology, 96, 1194-1199.

[13]   Heinz, F., Reckel, S. and Kalden, J.R. (1979) A New Spectrophotometric Assay for Enzymes of Purine Metabolism. Determination of Xanthine Oxidase Activity. Enzyme, 24, 239-246.

[14]   Tietz, N.W. (1999) Text Book of Clinical Chemistry. 3rd Edition, C.A. Burtis, E.R. Ashwood, W.B. Saunders, 1245-1250.

[15]   Tiffany, T.O., Jansen, J.M., Burtis, C.A., Overtin, J.B. and Scott, C.D. (1972) Enzymatic Kinetic Rate and End-Point Analysis of Substrate Using a Gemasec Fast Analyzer. Clinical Chemistry, 18, 829-840.

[16]   Klisic, J., Zhang, J., Nief, V., Reyes, L., Moe, O.W. and Ambuhl, P.M. (1972) Insulin Activates Na+/H+ Exchanger 3: Biphasic Response and Glucocorticoid Dependence. Journal of the American Society of Nephrology, 29, 308-316.

[17]   Lineweaver, H. and Burk, D. (1934) The Determination of Enzyme Dissociation constants. Journal of the American Chemical Society, 19, 658.

[18]   Price, N.C. and Stevens, L. (2003) Fundamentals of Enzymology: The Cell and Molecular Biology of Catalytic Proteins. 3rd Edition, Oxford University Press, New York, 133.

[19]   Ande Walle, J.G., Donckerwolcke, R.A. and Koomans, H.A. (1999) Pathophysiology of Edema Formation in Children with Nephrotic Syndrome Not Due to Minimal Change Disease. Journal of the American Society of Nephrology, 10, 323-331.

[20]   Duann, P., Datta, P.K., Pan, C., Blumberg, J.B., Sharma, M. and Lianos, E.A. (2006) Superoxide Dismutase Mimetic Preserves the Glomerular Capillary Permeability Barrier to Protein. Journal of Pharmacology and Experimental Therapeutics, 316, 1249-1254.

[21]   Gwinner, W., Scheuer, H., Haller, H., Baandes, R.B. and Gronene, H.J. (2005) Pivotal Role of Xanthine Oxidase in the Initiation of Tubulointerstitial Renal Injury in Rats with Hyperlipidemia. Kidney International, 69, 481-487.

[22]   George, J. and Struthers, A.D. (2009) Role of Urate, Xanthine Oxidase and the Effects of Allopurinol in Vascular Oxidative Stress. Vascular Health and Risk Management, 5, 265-275.

[23]   Dakshinamurty, K.V., Srinivasa, P. V., Saibaba, K.S.S., Sheela, R.B. and Venkataramana, G. (2002) Antioxidant Status in Patients on Maintenance Haemodialysis. Indian Journal of Nephrology, 57, 77-80.

[24]   Ni, Z. and Vaziri, N.D. (2003) Downregulation of Nitric Oxide Synthase in Nephrotic Syndrome: Role of Proteinuria. Biochimica et Biophysica Acta, 1638, 129-137.

[25]   Hamm, L.L. and Batuman, V. (2003) Edema in the Nephritic Syndrome: New Aspect of an Old Engima. Journal of the American Society of Nephrology, 14, 3288-3289.

[26]   Hodson, E., Willis, N. and Craig, J. (2007) Corticosteroid Therapy for Nephrotic Syndrome in Children. The Cochrane Database of Systematic Reviews, 17, 1533.

[27]   George, J., Carr, E., Davies, J., Belch, J.J.F. and Struthers, A. (2006) High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid. Circulation, 114, 2508-2516.

[28]   Baldus, S., Koster, R., Chumley, P., Heitzer, T., Rudolph, V. and Ostad, M.A. (2005) Oxypurinol Improves Coronary and Peripheral Endothelial Function in Patients with Coronary Artery Disease. Free Radical Biology & Medicine, 31, 1184-1190.

[29]   Higgins, P., Dawson, J. and Walters, M. (2009) The Potential for Xanthine Oxidase Inhibition in the Prevention and Treatment of Cardiovascular and Cerebrovascular Disease. Cardiovascular Psychiatry and Neurology, 28, 59.

[30]   Brown, E.A. (1985) The Nephrotic Syndrome. Postgraduate Medical Journal, 61, 1057-1062.